NO800664L - Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater - Google Patents

Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater

Info

Publication number
NO800664L
NO800664L NO800664A NO800664A NO800664L NO 800664 L NO800664 L NO 800664L NO 800664 A NO800664 A NO 800664A NO 800664 A NO800664 A NO 800664A NO 800664 L NO800664 L NO 800664L
Authority
NO
Norway
Prior art keywords
preparation
analogy procedure
hydroxypyrimidine derivatives
hydroxypyrimidine
derivatives
Prior art date
Application number
NO800664A
Other languages
English (en)
Other versions
NO154054C (no
NO154054B (no
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO800664(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of NO800664L publication Critical patent/NO800664L/no
Publication of NO154054B publication Critical patent/NO154054B/no
Publication of NO154054C publication Critical patent/NO154054C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO800664A 1979-03-10 1980-03-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. NO154054C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (3)

Publication Number Publication Date
NO800664L true NO800664L (no) 1980-09-11
NO154054B NO154054B (no) 1986-04-01
NO154054C NO154054C (no) 1986-07-09

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO800664A NO154054C (no) 1979-03-10 1980-03-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.

Country Status (24)

Country Link
JP (1) JPS55122768A (no)
AR (1) AR222691A1 (no)
AU (1) AU533547B2 (no)
BE (1) BE881752A (no)
CA (1) CA1132561A (no)
CH (1) CH644368A5 (no)
DE (3) DE3009071C2 (no)
EG (1) EG14282A (no)
FI (1) FI66357C (no)
FR (2) FR2451191A1 (no)
GB (1) GB2045756B (no)
HK (1) HK55383A (no)
IE (1) IE49547B1 (no)
IN (1) IN153791B (no)
LU (1) LU82185A1 (no)
MX (1) MX6218E (no)
MY (1) MY8400200A (no)
NL (1) NL184833C (no)
NO (1) NO154054C (no)
NZ (1) NZ192927A (no)
OA (1) OA06484A (no)
PT (1) PT70882A (no)
SE (1) SE435180B (no)
SG (1) SG22683G (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
IE49547B1 (en) 1985-10-30
FI66357C (fi) 1984-10-10
HK55383A (en) 1983-11-25
FI800566A (fi) 1980-09-11
GB2045756B (en) 1983-01-26
DE3009071A1 (de) 1980-09-11
EG14282A (en) 1983-09-30
NZ192927A (en) 1981-07-13
JPS55122768A (en) 1980-09-20
SE435180B (sv) 1984-09-10
DE3050999C2 (de) 1986-08-14
PT70882A (en) 1980-03-01
LU82185A1 (fr) 1980-06-06
DE3016752A1 (de) 1980-12-04
NL184468B (nl) 1989-03-01
IN153791B (no) 1984-08-18
FR2451191A1 (fr) 1980-10-10
NO154054C (no) 1986-07-09
OA06484A (fr) 1981-07-31
SE8001812L (sv) 1980-09-11
NL184833C (nl) 1989-11-16
DE3050999A1 (no) 1985-08-14
FR2451191B1 (no) 1983-04-29
DE3009071C2 (de) 1985-11-14
SG22683G (en) 1983-12-16
FI66357B (fi) 1984-06-29
GB2045756A (en) 1980-11-05
FR2451370B1 (no) 1983-05-13
CH644368A5 (en) 1984-07-31
MX6218E (es) 1984-12-21
FR2451370A1 (fr) 1980-10-10
NL184833B (nl) 1989-06-16
AU533547B2 (en) 1983-12-01
JPS6126996B2 (no) 1986-06-23
AR222691A1 (es) 1981-06-15
AU5624880A (en) 1980-09-18
CA1132561A (en) 1982-09-28
DE3016752C2 (no) 1987-06-25
IE800477L (en) 1980-09-10
NO154054B (no) 1986-04-01
NL8001289A (nl) 1980-09-12
MY8400200A (en) 1984-12-31
BE881752A (fr) 1980-05-30

Similar Documents

Publication Publication Date Title
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
DK146962C (da) Analogifremgangsmaade til fremstilling af indolizinderivater
DK155669C (da) Analogifremgangsmaade til fremstilling af pleuromutilinderivater
DK158984C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO800664L (no) Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater
DK156643C (da) Analogifremgangsmaade til fremstilling af naphthalensulfonamidderivater
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
DK522180A (da) Fremgangsmaade til fremstilling af indolderivater
DK154434C (da) Analogifremgangsmaade til fremstilling af tripeptidderivater
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO793103L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
NO803115L (no) Fremgangsmaate for fremstilling av stivelselim
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater